Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological Profile in Post-polio Syndrome
NCT03396783Completed
- Sponsor
- CHU Montpellier
- Start
- Dec 2017
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHU Montpellier. Primary endpoints: Cytokines blood concentrations and Lymphocytes blood concentrations. Started Dec 2017; status: completed.
Beyond the preview
Go deeper on NCT03396783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03396783.